Tagged with R&D

Turkey Recep Altekin, the general manager of MT Sağlik – market leader in Turkey for blood glucose monitoring systems and diabetes test strips by volume – tells PharmaBoardroom about his company’s impact on the Turkish medical device industry, and the value-added solutions that come packaged under the MT umbrella. Can you break…

Chiesi Chiesi is preparing to market two first in class products: the first approved stem cell treatment in Europe, and the first approved gene-therapy, developed in the Netherlands by partner UniQure. General Manager Nether Maurits Huigen discusses the challenges his affiliate is facing to bringing these pioneering products to market, along…

manufacturing The chancellor of the Medical Sciences Campus of the University of Puerto Rico discusses the medical R&D projects the university is currently involved in, the fields in which the island has the most potential, and how the institution is tailoring its academic offer to suit the local needs of the…

Puerto Rico Verónica Cruz, PhD, executive vice president and COO of Puerto Rican consultancy ReComS Group, discusses the need to bring investments in the life science industry back to Puerto Rico while focusing on the country’s manufacturing strengths as a competitive advantage. What are the main challenges which ReComS is facing? Today…

strategic levels Umut Gökalp, managing director of Japan’s Sysmex in Turkey – a company specialising in in-vitro diagnostics – evaluates their approach to developing business opportunities in the Turkish medical device sector. He also describes how the company’s new reagent facility in Germany will help bolster it domestically and regionally. Can you tell us…

investment The new government of Mauritius has chosen pharmaceuticals, healthcare and life sciences as priorities for the country’s innovation economy. Pharmaboardroom spoke with Ameenah Gurib Fakim, president of the Republic of Mauritius, who outlined her country’s strengths, and the challenge of replacing the country’s conventional “sun and sand” image with life sciences. Mauritius’ successful growth…

R&D Today’s Thai pharmaceutical market requires companies to adapt new leadership styles and carry new medicines in order to adjust to the needs of patients and clients. T. Man Pharma’s motto: “committed, innovative and developing quality pharmaceutical products to meet international standards” is what the director of sales and marketing, and…

locals Tuğçe Koç describes the company’s initial aspirations in targeting the higher value-added therapeutic area of oncology and the type of market opportunities that are present domestically and internationally. With over 25 years of experience, Onko Koçsel has established a strong foothold in the Turkish pharmaceutical industry—first with the introduction of…

basic research The Thailand Center of Excellence for Life Sciences (TCELS) CEO shares his ambitions to make Thailand a place for innovative business practices, the organization’s role in promoting and supporting research and the unique role TCELS plays in creating a regulatory frameworks for the life sciences industry. What special experiences led…

Otsuka Thai Otsuka’s president explains the Otsuka Group’s commitment to Thailand, the tremendous potential they see in the market in light of the opening up of the ASEAN Economic Community and his personal ambitions to ensure the company remains on a successful path. What is the importance of the Otsuka Group’s…

hematology Dante Castillo, managing director of Haemonetics Puerto Rico, explains the acquisition of Pall Life Science’s blood division and how the affiliate can focus on R&D as a new untapped area of potential, a unique asset in the country typically better known for manufacturing. How did the transition from Pall Life…

locals The chairman and CEO of Santa Farma discusses how the Turkish pharmaceutical landscape has evolved in response to the government’s healthcare transformation programs. He also enumerates various strategic initiatives the company is pursuing to bolster its competitive positioning the market such as constructing new state-of-the-art production and R&D facilities, penetrating…